Belle Health Review
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Draper, UT DTC telehealth (Belle Health LLC, founded 2017) offering compounded semaglutide $119/mo and tirzepatide $199/mo (3-month bundle) with flat-rate pricing — no dose-escalation surcharge. Five named LegitScript-certified pharmacy partners (Striker, Strive, OptioRx, Enovex, Braun PharmaCare). LegitScript Certified. Free weekly dietitian sessions included. CAUTION: FDA Warning Letter 721795 issued 02/20/2026 for misbranding compounded GLP-1 products under FDCA 502(a)/502(bb).
Medium confidence · Last verified 2026-05-25 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Belle Health is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
Belle Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Flat-rate (all doses) | compounded | $119 |
| Flat-rate (all doses, 3-month bundle) | compounded | $199 |
✓ Pros
- •Five named LegitScript-certified compounding pharmacy partners (Striker, Strive, OptioRx, Enovex, Braun PharmaCare) — strongest pharmacy disclosure in the WLR directory
- •Flat-rate pricing structure ($119/mo semaglutide, $199/mo tirzepatide) does NOT escalate at higher doses
- •Free weekly registered-dietitian sessions included (head dietitian Megan Ostler, MS, RDN)
- •9-year operating history — founded 2017 by CEO Chase Jardine
- •LegitScript Certified
- •BBB A+ rating (not BBB-accredited)
- •30,000+ customers claimed
- •All 50 states
✗ Cons
- •FDA Warning Letter dated 02/20/2026 for misbranding compounded GLP-1 products — recent and serious federal action
- •Tirzepatide $199 price requires 3-month bundle commitment
- •Compounded medications are not FDA-approved
- •Multi-pharmacy partner model — patients may receive different formulations across orders
Ready to start with Belle Health?
Starting at $119/month. See current pricing and start your free consultation.
Sources & methodology
Our Belle Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Belle Health
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Belle Health?
Starting at $119/month. See current pricing and start your free consultation.